Milan: bullish cue from Philogen
(Teleborsa) - The Developer of biopharmaceutical products for the treatment of life-threatening conditions puts in a decidedly bullish performance, gaining +2.31%.The analysis of Philogen's share price on a weekly basis highlights its bullish trend line, as it outperforms the benchmark. Thus the share is showing a greater performance than the FTSE Italia Mid Cap.
The medium-term picture confirms that Philogen is in a positive phase. In the short-term chart the bullish tendency is less pronounced as prices test the high of 20.05. First support is at 19.6. The technicals favour a bearish development towards the imminent low of 19.3 in the near term.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 04-04-2025 12:30 PM
